DETECTION OF ANTINUCLEAR ANTIBODIES BY INDIRECT IMMUNOFLUORESCENCE INDOG SERA - COMPARISON OF RAT-LIVER TISSUE AND HUMAN EPITHELIAL-2 CELLS AS ANTIGENIC SUBSTRATE
H. Hansson et al., DETECTION OF ANTINUCLEAR ANTIBODIES BY INDIRECT IMMUNOFLUORESCENCE INDOG SERA - COMPARISON OF RAT-LIVER TISSUE AND HUMAN EPITHELIAL-2 CELLS AS ANTIGENIC SUBSTRATE, Journal of veterinary internal medicine, 10(4), 1996, pp. 199-203
Rat liver sections and a human epithelial cell line (HEp-2) were compa
red as substrates for the detection of antinuclear antibodies (ANA) in
the serum of normal dogs and dogs with suspected autoimmune disease,
using a standard indirect immunofluorescence (IIF) technique. Antibody
reactivity against rat hepatocyte nuclei was frequently found at low
serum dilutions in normal dog sera. Using rat liver sections, a minimu
m significant positive titer, allowing negativity in more than 95% of
normal dog sera, was found to be 1/100. With this titer, ANA positivit
y could be verified in 64 of 112 (57%) reanalysed serum samples from d
ogs with suspected autoimmune disease, earlier determined as ANA-posit
ive, No reactivity against nuclei of HEp-2 cells was observed in any o
f the normal dog sera analyzed at a screening dilution of 1/25. Using
this dilution as a minimum significant positive titer, 63 of the 112 (
56%) re-evaluated serum samples were positive. These 63 samples were f
rom the same dogs as the 64 samples that were positive on rat liver se
ctions. Thus, the 2 methods of ANA-IIF detected a nearly identical pop
ulation of dogs with suspected autoimmune disease once the level of si
gnificance of a positive titer was adjusted to >95% specificity for ea
ch method. HEp-2 cells were found to be superior to rat liver cryostat
e sections as ANA substrate because of their low reactivity with norma
l sera, and the ease of discernment of the ANA fluorescence pattern, T
he recognition and documentation of specific pattern types may give cl
ues to ANA subspecificities, which could prove useful if they are foun
d to correlate with well-defined subgroups of immune mediated clinical
diseases in dogs. Copyright (C) 1996 by the American College of Veter
inary Internal Medicine.